2023 共识声明:代谢性高铁蛋白血症的定义和分类

2023-02-17 国外遗传代谢性疾病专家组(统称) Nat Rev Endocrinol 发表于陕西省

高铁蛋白血症常与代谢功能障碍和脂肪肝有关,代谢性高铁蛋白血症反映了铁代谢的改变,促进铁在体内的积累,并与心脏代谢和肝脏疾病的风险增加有关。本文主要提出了更新的代谢性高铁蛋白血症的定义和临时分期系统。

中文标题:

2023 共识声明:代谢性高铁蛋白血症的定义和分类

英文标题:

Consensus Statement on the definition and classification of metabolic hyperferritinaemia

发布日期:

2023-02-17

简要介绍:

高铁蛋白血症常与代谢功能障碍和脂肪肝有关,代谢性高铁蛋白血症反映了铁代谢的改变,促进铁在体内的积累,并与心脏代谢和肝脏疾病的风险增加有关。本文主要提出了更新的代谢性高铁蛋白血症的定义和临时分期系统。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 共识声明:代谢性高铁蛋白血症的定义和分类.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9baeb1c002999273, title=2023 共识声明:代谢性高铁蛋白血症的定义和分类, enTitle=Consensus Statement on the definition and classification of metabolic hyperferritinaemia, guiderFrom=Nat Rev Endocrinol, authorId=0, author=, summary=高铁蛋白血症常与代谢功能障碍和脂肪肝有关,代谢性高铁蛋白血症反映了铁代谢的改变,促进铁在体内的积累,并与心脏代谢和肝脏疾病的风险增加有关。本文主要提出了更新的代谢性高铁蛋白血症的定义和临时分期系统。, cover=https://img.medsci.cn/Random/doctor-writing-prescription-or-medical-PDEMCBW.jpg, journalId=0, articlesId=null, associationId=1767, associationName=国外遗传代谢性疾病专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Fri Feb 17 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>高铁蛋白血症常与代谢功能障碍和脂肪肝有关,代谢性高铁蛋白血症反映了铁代谢的改变,促进铁在体内的积累,并与心脏代谢和肝脏疾病的风险增加有关。本文主要提出了更新的代谢性高铁蛋白血症的定义和临时分期系统。</p>, tagList=[TagDto(tagId=472063, tagName=代谢性高铁蛋白血症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=304, categoryName=罕见病, tenant=100), CategoryDto(categoryId=21072, categoryName=罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=472063, articleKeyword=代谢性高铁蛋白血症, articleKeywordNum=6, guiderKeywordId=472063, guiderKeyword=代谢性高铁蛋白血症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10422, appHits=44, showAppHits=0, pcHits=182, showPcHits=10378, likes=0, shares=13, comments=5, approvalStatus=1, publishedTime=Mon Feb 27 18:36:00 CST 2023, publishedTimeString=2023-02-17, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=dajiong, createdTime=Thu Feb 23 11:37:16 CST 2023, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 09:23:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=陕西省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 共识声明:代谢性高铁蛋白血症的定义和分类.pdf)])
2023 共识声明:代谢性高铁蛋白血症的定义和分类.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2116866, encodeId=3e8821168663a, content=跟进<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:39 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2116835, encodeId=0b60211683551, content=与遗传有关吗,第一次听到这个疾病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3c31528806, createdName=gqylhd, createdTime=Tue Feb 28 07:49:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2116865, encodeId=0ad121168656f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:19 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省)]
    2023-02-28 ms8000000652312461 来自江苏省
  2. [GetPortalCommentsPageByObjectIdResponse(id=2116866, encodeId=3e8821168663a, content=跟进<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:39 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2116835, encodeId=0b60211683551, content=与遗传有关吗,第一次听到这个疾病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3c31528806, createdName=gqylhd, createdTime=Tue Feb 28 07:49:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2116865, encodeId=0ad121168656f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:19 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省)]
    2023-02-28 gqylhd 来自山西省

    与遗传有关吗,第一次听到这个疾病

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2116866, encodeId=3e8821168663a, content=跟进<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:39 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2116835, encodeId=0b60211683551, content=与遗传有关吗,第一次听到这个疾病, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3c31528806, createdName=gqylhd, createdTime=Tue Feb 28 07:49:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2116865, encodeId=0ad121168656f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da618362393, createdName=ms8000000652312461, createdTime=Tue Feb 28 10:50:19 CST 2023, time=2023-02-28, status=1, ipAttribution=江苏省)]
    2023-02-28 ms8000000652312461 来自江苏省

    学习

    0